EMCURE PHARMACEUTICALS Limited IPO GMP

EMCURE PHARMACEUTICALS LIMITED was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives and is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

Emcure Pharmaceuticals IPO, a Book Built issue amounting to ₹1952.03 crores, consisting a Fresh Issue of 79.36 lakh Shares worth ₹800.00 crores and an offer for sale of 114.28 Lakh shares totalling ₹1,152.02 crores. The subscription period for the Emcure Pharmaceuticals IPO opens on July 3, 2024, and closes on July 5, 2024. The allotment is expected to be finalized on or about Monday, July 8, 2024, and the shares will be listed on the BSE NSE with a tentative listing date set on or about Wednesday, July 10, 2024.

The Share price band of Emcure Pharmaceuticals IPO is set at ₹960 to ₹1,008 equity per share, with a minimum lot size of 14 shares. Retail investors are required to invest a minimum of ₹14,112, while the minimum investment for High-Net-Worth Individuals (HNIs) is 15 lots (210 shares), amounting to ₹211,680.

Kotak Mahindra Capital Company Limited, Axis Capital Limited, Jefferies India Private Limited and J.P. Morgan India Private Limited are the book-running lead manager, Link Intime India Private Limited is the registrar for the Issue.

Emcure Pharmaceuticals Limited IPO GMP Today
The Grey Market Premium of Emcure Pharmaceuticals Limited IPO is expected in the range of ₹200 - ₹250 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Emcure Pharmaceuticals Limited IPO Allotment Status
Emcure Pharmaceuticals IPO allotment date is 08 July, 2024, Wednesday. Emcure Pharmaceuticals IPO Allotment will be out on 8th July 2024 and will be live on Registrar Website from the allotment date. Check Emcure Pharmaceuticals Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Emcure Pharmaceuticals Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Emcure Pharmaceuticals Limited IPO
Emcure Pharmaceuticals Issue Proceeds from the Fresh Issue will be utilized towards the following objects :
1. ₹600 Crore will be used for Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by their Company 
2. General corporate purposes.

Refer to Emcure Pharmaceuticals Limited RHP for more details about the Company.